Showing 2,521 - 2,540 results of 7,089 for search 'significantly ((((((lower decrease) OR (mean decrease))) OR (nn decrease))) OR (linear decrease))', query time: 0.31s Refine Results
  1. 2521

    Characteristics of studies (<i>n</i> = 22). by Kuo-Chuan Hung (8587392)

    Published 2024
    “…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …”
  2. 2522
  3. 2523
  4. 2524
  5. 2525

    Patients’ responses to EQ5-D items. by Walid Al-Qerem (3760027)

    Published 2024
    “…Moreover, patients with only an elementary education had significantly lower EQ5-D scores compared to those with a postgraduate education (-0.106, 95%CI (-0.190, -0.023), p = 0.013).…”
  6. 2526
  7. 2527
  8. 2528
  9. 2529

    Data Sheet 1_Trends in lower extremity peripheral arterial disease incidence since 1990 and forecasting future statistics using Global Burden of Disease 2021: a time-series analysi... by Jiacheng Li (826240)

    Published 2025
    “…Background<p>Lower extremity peripheral arterial disease (LEPAD) significantly affects quality of life and is associated with severe cardiovascular risks. …”
  10. 2530

    Baseline characteristics of the study sample<sup>β</sup>μ. by Osama Mohamed Ibrahim (12006954)

    Published 2024
    “…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
  11. 2531

    The flow diagram of the study (CONSORT, 2010). by Osama Mohamed Ibrahim (12006954)

    Published 2024
    “…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
  12. 2532
  13. 2533
  14. 2534
  15. 2535
  16. 2536

    Sensitivity analysis. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  17. 2537

    Characteristics of participants. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  18. 2538

    Participant Flowchart. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  19. 2539

    Stratified analyses. by Jiuming Li (11711375)

    Published 2025
    “…According to the follow-up, 271 (56.7%) were in the exclusive breastfeeding group and the rest in the non-exclusive breastfeeding group (n = 207, 43.3%). A significant decrease in exclusive breastfeeding rate was observed in the prolonged TTP group compared to the short TTP group (OR=0.46, 95% CI: 0.27–0.74). …”
  20. 2540